Scribe Therapeutics,
SCTXOther · NASDAQ · IPO July 2, 2026
01
Company Overview
Scribe Therapeutics, is filing to list on an exchange. Public information at this stage is limited to the IPO calendar entry; deeper detail typically becomes available closer to pricing via the company's S-1 / prospectus.
Scribe Therapeutics, is going public on an exchange on 2026-07-02.
Recent headlines
- Gene editing developer Scribe plots an IPObiopharmadive.com
Scribe noted its plans to go public on the Nasdaq stock exchange under the ticker symbol “SCTX.”
- Scribe Therapeutics247wallst.com
Scribe Therapeutics updated its IPO registration with Nasdaq backing, enlisting Goldman Sachs, Leerink Partners, ... on July 10, 2026.
- Scribe Therapeutics joins the IPO queuepharmaphorum.com
Scribe was founded in 2017 and plans to list on the Nasdaq under the SCTX ticker symbol. It had cash reserves of around $50 million as of ...
- Scribe Therapeutics Files for Nasdaq IPOm.investing.com
Scribe Therapeutics, a biotechnology company, has filed for an initial public offering (IPO) on the Nasdaq Global Market, revealing its intent ...
- Scribe Therapeutics IPO: Investment Opportunities & Pre-IPO Valuationsforgeglobal.com
Scribe Therapeutics filed a S1 on July 2, 2026 to list on NASDAQ with ticker SCTX. The Scribe Therapeutics IPO price does not exist at this time, as Scribe ...
02
AI Analysis
Possible growth narrative
Sits adjacent to Other — themes that are currently drawing meaningful capital and attention.
Risks
Newly public companies typically face limited operating history disclosure, lock-up expirations, and broader market sentiment swings around IPOs.
Volatility
Expect elevated price volatility in the first weeks of trading as supply and demand find balance.
Market attention
Recently listed — monitoring early trading activity and analyst initiations.
Educational summary only. Not investment advice.
03
Related Themes
04
IPO Information
- IPO date
- July 2, 2026
- Exchange
- NASDAQ
- Status
- Recently Listed
- Industry
- Other
- Valuation
- $75.0M raise
- Headquarters
- —
- Attention score
- 46 / 100
- Ticker
- SCTX